Open access · US-GOV
via ClinicalTrials.gov Clinical trial
The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population
Authors not listed
Wright State University · 2024
Abstract
The purpose of this study is to determine if the Fractionated Laser Resurfacing (FLR) procedure can protect one forearm/wrist from precancerous actinic keratosis (AKs) as well as prevent skin cancer in older subjects with active AKs. This study builds on a similar study ongoing at the Dayton Veterans Administration dermatology clinic. This study is also testing if a photograph of the skin can be used to predict where the AKs and an skin cancers will form.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-05-29 MST
Cite this
APA
Anonymous. (2024). The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population. <em>Wright State University</em>. https://clinicaltrials.gov/study/NCT06428721
Vancouver
Anonymous. The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population. Wright State University. 2024.
BibTeX
@misc{anon2024ThePre,
title = {The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population},
author = {Anonymous},
journal = {Wright State University},
year = {2024},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Wright State University 2018
Open access · US-GOV
Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia
Doncaster And Bassetlaw Hospitals NHS Foundation Trust 2023
Open access · US-GOV
Assessing Frailty and Its Impacts in Older Patients Facing Major Gastrointestinal Surgery
University of Göttingen 2012
Open access · US-GOV
Subcutaneous Rituximab and Intravenous Bendamustine in Very Elderly Patients or Elderly Medically Non Fit Patients ("Slow Go") With Aggressive CD20-positive B-cell
NovoBliss Research Pvt Ltd 2023
Open access · US-GOV
A Randomized, Double Blind, Two Arm, Parallel, Placebo-Controlled, Safety and Efficacy Study of Anti-Ageing and Skin Brightening Gel
Avon Products, Inc. 2022
Open access · US-GOV
16-Week Randomized Split-Face Efficacy Study of Cosmetic Formulations in Photoaged Pigmented Skin Subjects
Seoul National University Bundang Hospital 2013
Open access · US-GOV